These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 32868174

  • 21. Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study.
    Dwyer JP, Agiro A, Desai P, Oluwatosin Y.
    Adv Ther; 2023 Nov; 40(11):4777-4791. PubMed ID: 37606716
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P.
    J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
    [Abstract] [Full Text] [Related]

  • 24. Discontinuation of RAAS Inhibition in Children with Advanced CKD.
    van den Belt SM, Heerspink HJL, Kirchner M, Gracchi V, Thurn-Valsassina D, Bayazit AK, Niemirska A, Canpolat N, Kaplan Bulut I, Azukaitis K, Duzova A, Bacchetta J, Shroff R, Paripovic D, Özçakar ZB, Fidan K, Erdogan H, Gellermann J, Wühl E, de Zeeuw D, Melk A, Querfeld U, Schaefer F.
    Clin J Am Soc Nephrol; 2020 May 07; 15(5):625-632. PubMed ID: 32253275
    [Abstract] [Full Text] [Related]

  • 25. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
    Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS.
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul 01; 4(3):180-188. PubMed ID: 29726985
    [Abstract] [Full Text] [Related]

  • 26. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM.
    JAMA Netw Open; 2018 Nov 02; 1(7):e183874. PubMed ID: 30646338
    [Abstract] [Full Text] [Related]

  • 27. Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN.
    Chinnadurai R, Rengarajan S, Budden JJ, Quinn CM, Kalra PA.
    Am J Nephrol; 2023 Nov 02; 54(9-10):408-415. PubMed ID: 37725919
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease.
    Evans M, Palaka E, Furuland H, Bennett H, Linde C, Qin L, McEwan P, Bakhai A.
    BMC Nephrol; 2019 Jan 31; 20(1):31. PubMed ID: 30704421
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis.
    Paolillo S, Basile C, Dell'Aversana S, Esposito I, Chirico A, Colella A, Esposito G, Santo MD, Fierro MF, Carbone F, Marzano F, Amato C, Gargiulo P, Perrone Filardi P.
    Eur J Intern Med; 2024 Jan 31; 119():109-117. PubMed ID: 37648583
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.
    Ren H, Leon SJ, Whitlock R, Rigatto C, Komenda P, Bohm C, Collister D, Tangri N.
    Clin Kidney J; 2022 Sep 31; 15(9):1713-1719. PubMed ID: 36003673
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction.
    Pitt B, Rossignol P.
    Clin Pharmacol Ther; 2017 Sep 31; 102(3):389-391. PubMed ID: 28707341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.